The evolving role of interventional pulmonary in the interdisciplinary approach to the staging and management of lung cancer. Part III: diagnosis and management of malignant pleural effusions

Clinical Lung Cancer
K Y YonedaStefano Gasparini

Abstract

The diagnosis and management of a malignant pleural effusion can be one of the most vexing problems faced by physicians and their patients. Lung cancer is the most common primary tumor of origin with a prognosis that is limited, but variable and correlated with performance status (PS). Therefore, with a poor PS and known advanced lung cancer, establishing whether or not an effusion is malignant might not be necessary. Conversely, identifiable subsets of patients will have a much better survival, and establishing a definitive diagnosis could be of critical importance. In the great majority of cases, a diagnosis can be determined by serial thoracenteses with or without closed pleural biopsy. However, thoracoscopy is increasingly being utilized and can expedite the workup by obviating the need for repeated thoracenteses and/or closed pleural biopsy, while in the same setting providing definitive palliative treatment. Although studies comparing diagnostic and treatment strategies are limited, we will present the available data with the intention of providing the practicing oncologist with a practical strategy for the diagnosis and management of malignant pleural effusions due to lung cancer. The interventional pulmonologist can pla...Continue Reading

References

Feb 1, 1979·Thorax·A HirschJ Chrétien
Oct 1, 1977·Thorax·A CantóF París
Nov 1, 1977·The American Journal of Medicine·B Chernow, S A Sahn
Dec 30, 1976·The New England Journal of Medicine·G DewaldH Gordon
Oct 1, 1992·AJR. American Journal of Roentgenology·C J YuK T Luh
Feb 15, 1991·Annals of Internal Medicine·R Menzies, M Charbonneau
Mar 1, 1990·AJR. American Journal of Roentgenology·A N LeungR R Miller
Jul 1, 1989·The Annals of Thoracic Surgery·R D PageR J Donnelly
Dec 1, 1973·Archives of Internal Medicine·R W LightW C Ball
Aug 1, 1980·Thorax·I P MungallN J Cooke
May 1, 1996·Annals of Internal Medicine·J J DoyleR S Howard
Aug 1, 1997·The European Respiratory Journal·R W Light, H Hamm
Aug 1, 1997·The European Respiratory Journal·S A Sahn
Oct 23, 1997·Chest·T NarukeH Nakayama
Jan 23, 1998·Southern Medical Journal·M AshchiP O'Donovan
May 15, 1998·Respiration; International Review of Thoracic Diseases·E Martínez-MoragónF Sanchis
Jul 29, 1998·The Annals of Pharmacotherapy·R L ThompsonF R Matzinger
Mar 29, 2000·The Annals of Thoracic Surgery·J B PutnamL L DeFord
Apr 18, 2000·Chest·W G Petersen, R Zimmerman
Nov 9, 2000·American Journal of Respiratory and Critical Care Medicine·UNKNOWN American Thoracic Society
Mar 14, 2002·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Hans-Jurgen MagerFranz Schramel

❮ Previous
Next ❯

Citations

Oct 9, 2012·American Journal of Respiratory and Critical Care Medicine·Wei HuangShao-hua Lu
Feb 3, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Piseth NarinSokha Eav

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
M de Groot, G Walther
Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
Hong-Zhong YangSu-Jie Qu
© 2021 Meta ULC. All rights reserved